Unknown NA INTERVENTIONAL 3-arm NCT01260012

Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis

Study on the Role of Antioxidant Micronutrients on the Reversal of Schistosomal Peri-portal Fibrosis of the Liver.

Sponsor: Addis Ababa University

Conditions Liver Fibrosis Oxidative Stress Periportal Fibrosis Schistosomiasis

Interventions Praziquantel + placebo 2mths then antioxidant for 10 mths Praziquantel therapy and placebo as supplement Praziquantel+antioxidant Praziquantel+antioxidant suppl

Updated 5 times since 2017 Last updated: Dec 14, 2010 Started: Jan 31, 2010 Primary completion: Jun 30, 2013 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Liver Fibrosis and Oxidative Stress and is currently ongoing. Addis Ababa University leads this study, which shows 5 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Addis Ababa University
Sorlandet Hospital HF
Ullevaal University Hospital
University of Agder
University of Oslo

Data source: Addis Ababa University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Addis Ababa, Ethiopia